← Back
Data updated: Mar 10, 2026
ANNORA PHARMA
ImmunologyCardiovascularNeurology
ANNORA PHARMA is a generic drug manufacturer focused on Immunology, Cardiovascular, Neurology. Key products include PANTOPRAZOLE SODIUM.
2002
Since
51
Drugs
-
Trials
733
Approved (2yr)
Key Drugs
Recent Activity
BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
GABAPENTIN 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
LURASIDONE HYDROCHLORIDE 2026-02-24
Labeling
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
BRIVARACETAM 2026-02-23
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 29%
4 drugs
Cardiovascular 21%
3 drugs
Neurology 21%
3 drugs
Gastroenterology 14%
2 drugs
Infectious Disease 14%
2 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Infectious Disease, Neurology
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
AbbVie big-pharma
Immunology, Neurology, Infectious Disease
PAI HOLDINGS PHARM big-pharma
Infectious Disease, Neurology, Cardiovascular, Immunology
Active (31)
ELTROMBOPAG OLAMINE DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM BRIVARACETAM IVABRADINE HYDROCHLORIDE NITAZOXANIDE SAPROPTERIN DIHYDROCHLORIDE DARUNAVIR ELETRIPTAN HYDROBROMIDE VIGABATRIN SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE COLCHICINE DEFERASIROX SOLIFENACIN SUCCINATE PIOGLITAZONE HYDROCHLORIDE ZAFIRLUKAST EPLERENONE DIVALPROEX SODIUM OXCARBAZEPINE PANTOPRAZOLE SODIUM VENLAFAXINE HYDROCHLORIDE MESALAMINE LISINOPRIL FAMOTIDINE FLUVOXAMINE MALEATE ENALAPRIL MALEATE NABUMETONE DICLOFENAC POTASSIUM MEXILETINE HYDROCHLORIDE IBUPROFEN AMINOCAPROIC ACID NITROFURANTOIN
Discontinued (16)
Company Info
- First Approval
- 2002-07-01
- Latest
- 2025-10-02
- Applications
- 64